Loading tumor antigens into dendritic cells (DCs) during EV production along with poly(I:C) (a molecular pattern associated with viral infection) resulted in a vaccine capable of inducing strong activation of melanoma-specific CD8+T cells and recruitment of cytotoxic CD8+T cells [10]. This evidence concerns the gene CD8A and melanoma.